Logo for Zentalis Pharmaceuticals Inc

Zentalis Pharmaceuticals Investor Relations Material

Latest events

Logo for Zentalis Pharmaceuticals Inc

Study Update

Zentalis Pharmaceuticals
Logo for Zentalis Pharmaceuticals

Q4 2024

26 Mar, 2025
Logo for Zentalis Pharmaceuticals

Study Update

29 Jan, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies

Latest reports from Zentalis Pharmaceuticals Inc

Access all reports
Zentalis Pharmaceuticals Inc., operating under the ticker ZNTL on the NASDAQ, is a clinical-stage biopharmaceutical company with a dedicated focus on the discovery and development of small molecule therapeutics aimed at various cancer types. Its pipeline includes a variety of compounds in different stages of clinical trials, targeting key biological pathways in cancer. Zentalis Pharmaceuticals is headquartered in NYC and its shares are listed on the Nasdaq.